Xarelto Bleeding Lawsuit Trial Reschedules Due to NBA Game in New Orleans

   

Xarelto Bleeding Lawsuit Allege The Blood Thinner Causes Serious Bleeding Events And Fails To Prevent Blood Clots.

XareltoSouthern Med Law has recently learned that the initial trial for one of the Xarelto bleeding lawsuit scheduled for February has been postponed to March due to the NBA All-Star game in New Orleans. The federal courthouse where Xarelto bleeding lawsuits are consolidated in a multidistrict litigation is also located in New Orleans. The Xarelto lawsuits pending litigation and looking t allege that Bayer HealthCare, which manufactures Xarelto, and Janssen Pharmaceuticals Inc., which markets the blood thinner, failed to adequately warn that its product causes brain bleeds, blood clots, gastrointestinal hemorrhage and other side effects that may require hospitalization and have also caused death. (In Re: Xarelto Products Liability Litigation, Xarelto Bleeding Lawsuit Case No. 2592)

“We agree with the decision to postpone the trial to avoid disruptions a major event like the NBA All-Star game could create,” says Dr. François Blaudeau, attorney and founder of Southern Med Law.

The Xarelto bleeding lawsuit attorneys at Southern Med Law are strong advocates of helping patients who believe they have suffered Xarelto side effects. The firm has spoken with men and women from across the country who experienced serious bleeding events after taking Xarelto. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact the Firm to learn more about your legal rights and to arrange for a free, no obligation Xarelto lawsuit review by calling Southern Med Law today, at 205-547-5525 or visit www.southernmedlaw.com for more information and to fill out a contact form.

U.S. District Judge Eldon Fallon, who is presiding over the Xarelto MDL in the Eastern District of Louisiana, rescheduled the first two bellwether trials to March 13 and April 24, respectively, in New Orleans. The third bellwether trial was reset to May 30, in the Southern District of Mississippi. The fourth trial was initially scheduled for May in Texas but a rescheduling date was not included in Judge Fallon’s order issued on September 21. The first Xarelto bellwether trial was originally scheduled for February 6, 2017, prior to the start of the annual Mardi Gras festival. Parties in the Xarelto MDL asked for the change after the NBA announced in August that New Orleans would host the All-Star Game on February 19. (In Re: Xarelto Products Liability Litigation, No. 2592)
[espn.com/nba/story/_/id/17344903/nba-chooses-new-orleans-2017-all-star-game, ESPN, August 19, 2016]

Xarelto (rivaroxaban) is a popular anticoagulant approved by the U.S. Food and Drug Administration (FDA) to prevent strokes, deep vein thrombosis, pulmonary embolism, and blood clots in patients with atrial fibrillation not caused by a heart valve problem. The FDA considers Xarelto a new generation blood thinner compared to warfarin (Coumadin, Jantoven) which received FDA approval over 60 years ago. Bayer touts Xarelto as being more convenient for patients because they do not have to undergo routine blood monitoring like patients taking warfarin. The FDA has pointed out that unlike warfarin, Xarelto does not have an antidote to treat internal bleeding side effects. Warfarin uses vitamin K as a reversal agent for adverse bleeding events.
[fda.gov/Drugs/NewsEvents/ucm405148.htm, July 17, 2014]

Court documents show that the first Xarelto trial involves a plaintiff who was prescribed the blood thinner in January 2014 to reduce the risk of stroke due to atrial fibrillation. The plaintiff, however, suffered gastrointestinal bleeding allegedly as a result of taking Xarelto, and had to be hospitalized and have several blood transfusions, according to the Xarelto complaint. (Case No. 2:14-cv-02720, In Re: Xarelto Products Liability Litigation, No. 2592)

About Southern Med Law And Filing A Xarelto Bleeding Lawsuit

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one believe they where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525
Fax: 205-547-5526
francois@southernmedlaw.com

This entry was posted in Southern Med Law | Article. Bookmark the permalink.